In summary, these data suggest that BCR-ABL1T315I+ CML cells produce less fibronectin than BCR-ABL1+ cells and that fibronectin production by leukemia cells influences CML progression. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.